Biblio
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Support Care Cancer. 2023;32(1):36.
. Factors that Impact the Outcomes in Ewing's Sarcoma: Experience from a Regional Cancer Center in Southern India. Indian J Surg Oncol. 2024;15(1):35-43.
. Plasmablastic lymphoma - single centre experience with infusional EPOCH chemotherapy. Leuk Res. 2020;95:106391.
.